
|Articles|September 1, 2002
Up to 40% of cancers may not present clinically
Author(s)Scott Tennant
Seattle-Despite the way it was portrayed in some of the lay media, the authors of a recent study on the "overdiagnosis" of prostate cancer insist their work should not be construed as hostile to the practice of PSA screening. In fact, says one investigator, results of the study paint an overall favorable picture of screening.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
What the Efficacy Data from KEYNOTE-B15/EV-304 Revealed
2
Interpreting real-world evidence in ARPI treatment decisions, with Martin Schoen, MD, PhD
3
Higher saturated fat intake associated with increased mortality in nonmetastatic prostate cancer
4
FDA reports increased demand, supply efforts for estradiol transdermal patches
5






